Galera therapeutics reports q4 loss per share $1.31

Galera therapeutics reports fourth quarter and full year 2019 financial results and recent accomplishments.q4 loss per share $1.31.q4 earnings per share estimate $-0.55 -- refinitiv ibes data.galera therapeutics - as of december 31, 2019, galera had cash, cash equivalents and short-term investments of $112.3 million.galera therapeutics - expects cash, cash equivalents & short-term investments to fund operating expenses & capital expenditure requirements into 2022.
GRTX Ratings Summary
GRTX Quant Ranking